Evidence map›Paper›PMID 9439676›Full record

ArticleJapanese journal of cancer research : Gann1997

Germline mutations of the MEN1 gene in Japanese kindred with multiple endocrine neoplasia type 1.

S Shimizu, T Tsukada, H Futami, K Ui, T Kameya, M Kawanaka, S Uchiyama, A Aoki, H Yasuda, S Kawano and 4 more

Abstract read
In one paragraph

Article in Japanese journal of cancer research : Gann, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. A MEN1 syndrome with a paraganglioma.European journal of human genetics : EJHG · 2014
    Article
  5. Article
  6. Multiple endocrine neoplasia type 1.Orphanet journal of rare diseases · 2006
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

S ShimizuGrowth Factor Division, National Cancer Center Research Institute, Tokyo.
T Tsukada
H Futami
K Ui
T Kameya
M Kawanaka
S Uchiyama
A Aoki
H Yasuda
S Kawano
Y Ito
M Kanbe
T Obara
K Yamaguchi

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant familial cancer syndrome. The responsible gene MEN1 has recently been isolated, and its germline mutations have been identified in affected individuals in the United States, Canada and Europe. We screened for MEN1 mutations by direct nucleotide sequencing of all protein-coding regions, and identified five distinct germline mutations in five among six Japanese kindreds with familial MEN1 or familial hyperparathyroidism. The mutations were dispersed across the gene. These findings suggest that, because of the absence of an obvious founder effect, the entire MEN1 gene region should be examined for germline mutations in the probands of MEN1 and related syndromes in Japanese families.

Indexed as

Germ-Line MutationDNA, NeoplasmFamily HealthHumansMultiple Endocrine Neoplasia Type 1Polymerase Chain ReactionDNA, Neoplasm

Identifiers

PMID9439676
PMCPMC5921317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.